Stéphane Bancel, Moderna CEO (Charles Krupa/AP Images)

Mod­er­na beats Pfiz­er to the punch, files EUA for Covid-19 vac­cine for youngest chil­dren

Covid-19 vac­cines for the youngest group of chil­dren (un­der the age of six) may soon be avail­able ⁠— po­ten­tial­ly in the next month ⁠— as Mod­er­na an­nounced on Thurs­day morn­ing that it has sub­mit­ted an EUA re­quest to the FDA.

The FDA still needs to re­view the ap­pli­ca­tion, which is based on da­ta un­veiled late last month show­ing a ro­bust neu­tral­iz­ing an­ti­body re­sponse in the 6 month to un­der 6 years age group af­ter a two-dose se­ries of the vac­cine, along with a fa­vor­able safe­ty pro­file. The FDA still needs to set up an ad­vi­so­ry com­mit­tee of out­side ex­perts to re­view the da­ta.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.